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ABSTRACT
PURPOSE: For gay and bisexual men (GBM), research suggests that familiarity with PreExposure Prophylaxis (PrEP) has been increasing since being approved by the U.S. FDA in
2012. However, it is less clear how willingness to start using PrEP has changed over time.
Likewise, some have expressed concerns regarding the potential for risk compensation (i.e.,
reduced condom use) were one to start PrEP; however, again, it is unclear how these may have
been changing over time.
METHODS: We conducted baseline and 12 month assessments with 158 highly sexually active
HIV-negative GBM in NYC who were assessed between 2011 and 2014. We examined change
over time both between participants (based on when they entered the study), as well as within
each participant (over the 12 months of his involvement).
RESULTS: Familiarity with PrEP increased over time (both between and within participants);
however, willingness to take PrEP did not change (neither between nor within participants). Few
men believed taking PrEP would cause their condomless anal sex (CAS) to increase and this did
not change over time. However, a majority believed PrEP would increase temptation for CAS,
and this did not change over time within participants. Sexual compulsivity (SC) symptomology
was associated with higher willingness to take PrEP and perceiving that PrEP would increase
one’s temptations for CAS. Furthermore, recent CAS was associated with greater willingness to
take PrEP, a perception that PrEP would increase one’s likelihood to engage in CAS, and a
perception that being on PrEP would increase one’s temptation for CAS.
CONCLUSIONS: Participants became more familiar with PrEP over time; however,
willingness to start PrEP did not change, and this may serve as an opportunity for providers to
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discuss PrEP with their patients. Higher risk men were interested in PrEP and pre-existing
patterns of sexual behavior may be the primary determinant of CAS while on PrEP.
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Introduction
Gay and bisexual men (GBM) continue to be disproportionately affected by HIV in the
United States, making up 84% of new infections among men.1 In July 2012, the United States
Food and Drug Administration (FDA) approved once-daily Truvada (emtricitabine/tenofovir
disproxil fumarate) for use as Pre-Exposure Prophalyxis (PrEP) to prevent HIV transmission to
HIV-negative individuals. It has been recommended by both the Centers for Disease Control and
Prevention (CDC) and the World Health Organization (WHO).2,3 Among GBM, evidence from
several studies suggests that familiarity with PrEP has been increasing over time from reported
ranges of 11% in 2010-20114 to 54% in 2014.5 However, it is less clear how willingness to start
PrEP has changed over time. Research addressing willingness to start PrEP has varied from 2880% with most studies reporting 50% or higher.4 Anecdotal data suggest that there are multiple
barriers to beginning PrEP including stigma attached to using PrEP,6 fears around side effects
and potential drug resistance to future forms of HIV biomedical prevention.7
Likewise, some researchers and popular media outlets have expressed concerns regarding
the potential for risk compensation via reduced condom use (i.e., biological risks are decreased
due to PrEP and so condom use decreases).8 A PrEP demonstration project from three cities
(San Francisco, Miami, and Washington D.C.) conducted between 2012 and 2015 that followed
participants for 48 weeks found that the average number of anal sex partners declined during
follow-up from 10.9 to 9.3, whereas the proportion engaging in condomless receptive anal sex
remained stable at 66%.9 Although STI incidence was high (90 infections per 100 person-years),
it did not increase over time. Only two individuals contracted HIV, both of whom had plasma
levels of PrEP consistent with fewer than two doses per week at seroconversion.10 A recent San
Francisco study of men on PrEP reported no new HIV infections over a 2.5 year period, while
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more than half of participants had contracted an STI, which suggests low rates of condom use
while on PrEP, though rates of condom use prior to beginning PrEP were not reported.11
To provide insights into changes in familiarity with PrEP as well as willingness to start
PrEP, we conducted baseline and month 12 assessments with highly sexually active gay and
bisexual men assessed between 2011 and 2014. At both time points we assessed for familiarity
with PrEP and willingness to start PrEP. In addition, we assessed for perceived effect of PrEP on
condomless anal sex (CAS) as well as temptation for CAS.
Method
Analyses for this article were conducted on data from Pillow Talk, a longitudinal study of
highly sexually active (i.e., ≥ 9 male partners in 90 days) gay and bisexual men in New York
City (NYC).12 Participants were recruited using a combination of strategies: (1) respondentdriven sampling; (2) Internet-based advertisements on social and sexual networking websites; (3)
email blasts through NYC gay sex party listservs; and (4), active recruitment in NYC venues
such as gay bars/clubs, concentrated gay neighborhoods, and ongoing gay community events.
Enrollment began in February 2011 and closed in June 2013. Participants were followed
for a period of 12 months. Data for this article were taken from the baseline and 12 month visits
(the last participant completed his 12 month assessment in June 2014). The project enrolled both
HIV-negative and HIV-positive men, though the analyses for this article were limited to HIVnegative men. Of the 376 men who enrolled in the project, 207 (55.2%) were confirmed to be
HIV-negative with a rapid HIV antibody test during their baseline assessment—two of these
participants tested HIV-positive at their 12-month assessment and were excluded. One of these
men was missing necessary data at baseline, 42 individuals did not return for their 12-month
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assessment, and four were missing necessary data at the 12-month assessment. Thus, analyses
focused on a sample of 158 participants.
Participants and Procedures
To be eligible, participants had to be at least 18 years of age, biologically male and selfidentified as male, report nine or more male sexual partners in the prior 90 days, self-identified as
gay, bisexual, or some other non-heterosexual identity (e.g., queer), and have access to the
Internet. Participants were emailed a link to an Internet-based computer-assisted self-interview
(CASI), which included informed consent procedures. Men completed this one-hour online
survey at home followed by an in-person baseline appointment and the same procedures were
followed for the 12-month assessment. In-person assessments included a structured timeline
follow-back (TLFB) interview in which a calendar is used to recall one’s daily sexual behavior
and substance use.13 Final eligibility and enrollment was confirmed during the in-person
appointment. All procedures were reviewed and approved by the City University of New York
Institutional Review Board.
Measures
Measures used for this article were taken from the baseline and 12-month assessment.
Using a computer-assisted survey, participants reported demographic characteristics, including
sexual identity, age, race/ethnicity, education, and relationship status. Participants also
completed the 10-item Sexual Compulsivity Scale (SCS; α = 0.91).14,15 The SCS has been shown
to have high reliability and validity across multiple studies.16,17 A score of 24 was used as a
cutoff indicative of experiencing problematic levels of sexual compulsivity.18-21
At baseline and month 12, participants were presented with the following brief summary
of PrEP:22
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“PrEP (pre-exposure prophylaxis) is a new biochemical strategy to prevent HIV
infection. PrEP involves HIV-negative guys taking anti-HIV medications (for example,
Truvada) once a day, every day to reduce the likelihood of HIV infection if they were
exposed to the virus. The first clinical trial of PrEP indicated that it reduced the
likelihood of HIV infection when used in combination with other preventative methods,
such as condoms.”
Participants then responded to a series of single-item questions regarding PrEP.
Familiarity with PrEP. Participants were asked how familiar they were with PrEP (I’ve
never heard of it before today; I’ve heard about it, but I don’t really know what it was; I know a
little bit about it; I know a fair amount about it; I know a lot about it). Those indicating they
knew a fair amount or a lot were coded as being familiar with PrEP (0 = no, 1 = yes).
Willingness to take PrEP. Participants were asked how likely they would be to take
PrEP if it were at least 40% effective and offered to them for free (“definitely,” “probably,”
“might,” “probably not,” “definitely not”). Those who said they would probably or definitely
take it were coded as being likely to take PrEP (0 = no, 1 = yes).
Likelihood of engaging in CAS. Men were also asked how taking PrEP would influence
their likelihood to engage in condomless anal sex (“significantly more likely,” “somewhat more
likely,” “would not change,” “somewhat less likely,” “significantly less likely.”). The variable
was dichotomized to reflect those who responded that PrEP would make them somewhat or
significantly more likely to engage in CAS (0 = no, 1 = yes).
Temptation to engage in CAS. Men were asked “How do you think taking PrEP would
impact your temptation to have sex without condoms?” with Likert-type responses on a 7-point
scale. The anchor points were -3 = “much less tempted,” 0 = “no impact,” and +3 = “much more
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tempted.” This variable was dichotomized with those indicating 1 through 3 coded as having
increased temptation for CAS (0 = no, 1 = yes).
During the TLFB interview, we collected data on CAS with any male partners in the prior
6 weeks (42 days), dichotomized 1 = yes, 0 = no. In addition, we collected data on instances of
club drug use (ketamine, MDMA/ecstasy, GHB, cocaine, crystal methamphetamine) in the past 6
weeks, dichotomized 1 = yes, 0 = no.
Analytic Plan
We calculated the month of enrollment during which each participant joined (0 through
27) and created a dichotomous variable indicating the type of visit (baseline = 0, 12-month
follow-up = 1). We created a dichotomous variable indicating whether or not each visit occurred
after the FDA approval of PrEP on July 16, 2012.
We conducted multilevel modeling examining the effect of between-person enrollment
month (0 through 27) and within-person visit type (Baseline vs. 12 month) on PrEP familiarity,
willingness to take PrEP, and perceived influence of PrEP on likelihood and temptation to
engage in CAS. All models were adjusted for time-invarying covariates (age, White race, sexual
identity, and college education or higher which were all measured at baseline), as well as three
time-varying covariates (relationship status, whether or not the FDA had yet approved PrEP (i.e.,
data collected before and after July 2012), and whether or not the participant had engaged in any
CAS with a male partner at each assessment point). Throughout the results we distinguish
between-person (i.e., time invariant) versus within-person (i.e., time-varying) effects within the
multilevel models. In reference to the effect of time, the between-person effect references the
time when individuals began the study and can be interpreted as the change in the odds of the
outcome for an individual who started the study later than another individual. The within-person
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effect of time compares each individual’s odds of the outcome after 12 months of being enrolled
in the study compared to his own odds at baseline.
Results
As seen in Table 1, the sample was diverse at baseline with regards to race/ethnicity and
educational attainment, whereas a majority of the sample was gay-identified and single. At
baseline, 22.8% were familiar with PrEP, 46.8% expressed willingness to take PrEP, 25.3%
believed PrEP would increase their likelihood to engage in CAS, and 58.2% believed PrEP
would increase their temptation to engage in CAS. By the 12-month assessment, the numbers
familiar with PrEP and who believed their likelihood of CAS would increase on PrEP had both
grown somewhat, whereas the numbers who were willing to take PrEP and who believed their
temptation for CAS would increase on PrEP had slightly declined. More than half of the sample
had engaged in CAS at baseline and this declined to about half at follow-up, whereas
approximately one-quarter had used club drugs at baseline and this increased to nearly 30%. It is
worth noting that there was a decline in the number of male partners men reported from baseline
to follow-up as well.
After adjusting for both demographic and behavioral characteristics in the model, the
odds of being familiar with PrEP increased significantly between participants by 10% per month
from the beginning to the end of enrollment but not within participants from baseline to followup (see Table 2).. This suggests that individuals who started the study later had greater
familiarity with PrEP than individuals who started the study earlier, but each individual’s
familiarity was unchanged over the 12 months he was enrolled. The adjusted odds of being
willing to take PrEP, perceiving that being on PrEP would increase the likelihood of engaging in
CAS, and perceiving that being on PrEP would increase temptation to engage in CAS all
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remained stable both between and within participants over time. This suggests that individuals
who started the study later were no different than individuals who started the study earlier and
individuals, on average, did not change over the course of their enrollment.
It is also worth noting the significant associations of covariates within the models. At the
between-participant level, gay men had higher odds than bisexual men of being willing to take
PrEP, men with at least a college degree had lower odds than men with less education of being
willing to take PrEP, and White men had higher odds than non-White men of believing PrEP
would increase their likelihood of engaging in CAS. At the within-person level, reporting club
drug use during a visit was associated with higher odds of also reporting familiarity with PrEP
during that visit. Reporting sexual compulsivity (SC) symptomology was associated with higher
odds of reporting willingness to take PrEP as well as perceiving that PrEP would increase one’s
temptations for CAS during the same visit. Furthermore, reporting CAS prior to a visit was
associated with higher odds of reporting during the same visit a willingness to take PrEP, a
perception that PrEP would increase one’s likelihood to engage in CAS, and a perception that
being on PrEP would increase one’s temptation for CAS.
Discussion
Pillow Talk was a study of highly sexually active gay and bisexual men—individuals
who are excellent candidates for PrEP based on WHO and CDC criteria/guidance.2,3,23 Our data
demonstrated that individuals who started the study later had higher familiarity with PrEP,
though there was no increase in each individual’s level of familiarity over the year he was in the
study. Willingness to take PrEP was the same regardless of when individuals began the study and
also did not change within individuals over the course of their enrollment; however, it is
important to note that nearly half of participants were willing to take PrEP if it was free. It may
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be that willingness to start PrEP is the result of relatively stable individual-level factors that are
more resistant to change over time, such as not believing that one would be an appropriate
candidate for PrEP2 or stigma attached to using PrEP,8 neither of which was measured in this
study. The results of this study highlight the need to identify barriers to PrEP uptake amidst
increasing familiarity.
Few men believed taking PrEP would cause their CAS to increase and we did not find
evidence that this changed over time. A majority of participants believed PrEP would increase
temptation for CAS, but this also did not appear to change over time. These findings suggest the
importance of investigating differences between temptation and likelihood as well as their impact
on actual changes in CAS among men before and after they start PrEP. Furthermore, although
risk compensation is of concern for STIs, it also remains important for researchers to both
investigate and acknowledge the intrinsic benefits of CAS such as increased sexual pleasure and
feelings of connectedness.24,25 Likewise, researchers must acknowledge the relative risks of STI
transmission and treatment versus HIV transmission and treatment.
The results of this study should be understood in light of their limitations. To be eligible
for Pillow Talk, men had to report at least 9 male partners in the prior 90 days. This sample
represents, by definition, a priority population for PrEP; however, these men do not represent all
GBM. One strength of our study was the assessment of changes between baseline and 12
months; however, we recognize that both a longer assessment window and/or more incremental
assessment points would have benefited this study. It would be important to replicate this study
today in light of emerging data highlighting consistently the effectiveness of PrEP in
community-based settings.9,11 Furthermore, we acknowledge that by virtue of asking participants
about PrEP we are in-fact exposing them to information about PrEP, and this may have

12
contributed to our findings regarding increased knowledge over time. We did not assess where or
how participants were learning about PrEP, and thus cannot attest to the magnitude of test-retest
effects attributable to this study. Enrollment for this study began before data on clinical trials
regarding PrEP’s effectiveness were available. Thus, we used a conservative estimate of 40%
effectiveness when describing PrEP to participants. This number was in line with initial data on
PrEP’s effectiveness;26 however, early findings included individuals who were prescribed PrEP
but did not have detectable levels of PrEP in their bloodstream (i.e., were not taking PrEP). We
now know that PrEP is much more effective when taken as prescribed11 and this new-andemerging information will likely have a significant impact on men’s decisions to use PrEP today.
In essence, were revised estimates of effectiveness presented to participants, we might have
observed different values for both uptake as well as the perceived impact on CAS.
We do not have data on reasons why individuals were unwilling to take PrEP and our
findings indicate that enough individuals were unwilling to do so that further consideration is
warranted, perhaps through qualitative methods like semi-structured interviews and/or focus
groups. The results of this study concerned hypothetical PrEP initiation. As PrEP continues to
diffuse as a new prevention strategy, it is important to continue to investigate how PrEP will
affect both perceived and actual sexual behaviors of GBM. Our measure of temptation to have
sex without condoms did not specify anal sex; however, we believe strongly that participants
understood this to mean anal sex. Finally, sexual behavior decreased among participants in our
study over time, and this was controlled for in our analyses, but we did not have data as to why
behavior decreased. It may be that because frequency was so high at baseline we observed a
statistical regression toward the mean.
Conclusion
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Gay and bisexual men became more aware of PrEP as enrollment for Pillow Talk
continued in time, and this may be largely a result of the recent growth of both traditional and
social media campaigns to promote PrEP education and dissemination (e.g.,
myPrEPexperience.blogspot.com, whatisPrEP.org, PrEPforsex.org, #TruvadaWhore on Twitter
and Facebook); however, the actual effect of PrEP promotion campaigns was not measured in
this study. Nevertheless, in this study, willingness to use PrEP did not change over time. To what
extent was stagnant willingness to start PrEP a result of combined concerns regarding
effectiveness, access, side effects, and fear of stigma? The potential for risk compensation
seemed low (and unchanged over time); however, participants’ temptation for CAS as a result of
PrEP was high. Data gathered from men before and after starting PrEP are necessary to discern
the actual impact of PrEP in real world settings, and we suggest that researchers weigh the
intrinsic benefits associated with CAS in the event of risk compensation.
With the expansion of PrEP uptake, some have expressed concerns regarding risk
compensation; however, less is mentioned about behavioral disinhibition. Risk compensation
could be conceptualized as between subjects differences in cognitions and attitudes that
differentially predict engagement in CAS (e.g., level 2 predictor); whereas, behavioral
disinhibition could be conceptualized as changes in behaviors on average over time (e.g.,
between and within subjects changes in outcomes over time). Our findings suggest a need to
collect data on and assess for risk compensation as well as behavioral disinhibition.
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Table 1.
Demographic and background characteristics of the sample (N = 158)
Baseline
12-Month
n
%
n
%
Race/Ethnicity
Black
24 15.2
--Latino
19 12.0
--White
93 58.9
--Other/multiracial
22 13.9
--Sexual Orientation
Gay
132 83.5
--Bisexual
26 16.5
--Educational Attainment
Less than a bachelor's degree
46 29.2
--Bachelor's degree
62 39.2
--Graduate degree
50 31.6
--Relationship Status
Single
134 84.8
114 72.2
Partnered
24 15.2
44 27.8
Familiar with PrEP
No
122 77.2
107 67.7
Yes
36 22.8
51 32.3
Willing to take PrEP
No
84 53.2
87 55.1
Yes
74 46.8
71 44.9
Likelihood of CAS on PrEP
No
118 74.7
113 71.5
Yes
40 25.3
45 28.5
Temptation for CAS on PrEP
No
66 41.8
77 48.7
Yes
92 58.2
81 51.3
Any CAS
No
63 39.9
78 49.4
Yes
95 60.1
80 50.6
Any club drug use
No
118 74.7
111 70.3
Yes
40 25.3
47 29.7

Age
Number of male partners

M
34.8
12.2

SD
12.2
8.2

M
-6.6

Note. Race/ethnicity, sexual orientation, educational attainment, and age
were assessed once and fixed over time.

SD
-6.2
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Table 2.
Longitudinal models examining predictors of PrEP-relevant factors
PrEP Familiarity
B
AOR
95% CI
Between-Participant Factors (Level 2)
Age
0.03
1.03
0.99, 1.06
White race (ref = non-White)
-0.41
0.66
0.31, 1.44
Gay (ref = bisexual)
0.82
2.28
0.80, 6.45
College degree (ref = no)
-0.26
0.77
0.34, 1.75
Month of enrollment
Within-Participant Factors (Level 1)
Partnered (ref = single)
Club drug use (ref = no)
SC symptomology (ref = no)
FDA approved PrEP (ref = no)
Any CAS reported (ref = no)
12-month assessment (ref = baseline)b

Month of enrollment
Within-Participant Factors (Level 1)
Partnered (ref = single)
Club drug use (ref = no)
SC symptomology (ref = no)
FDA approved PrEP (ref = no)
Any CAS reported (ref = no)

Willingness to Take PrEP
AOR
95% CI

-0.01
-0.06
0.93
-0.92

0.10

1.10**

1.02, 1.19

0.04

-0.36
0.89
-0.40
0.32
0.27

0.70
2.44*
0.67
1.37
1.31

0.30, 1.64
1.12, 5.30
0.33, 1.37
0.47, 3.98
0.66, 2.61

-0.55
0.11
0.62
-0.52
0.79

0.48

1.61

0.78, 3.35

0.35

Likelihood of CAS on PrEP
B
AOR
95% CI
Between-Participant Factors (Level 2)
Age
Gay (ref = bisexual)
White race (ref = non-White)
College degree (ref = no)

B

-0.02
0.39
1.04
0.21
0.03
-0.16
0.10
0.30
-0.49
1.71

0.99
0.94
2.53*
0.40**

0.97, 1.02
0.50, 1.76
1.11, 5.74
0.21, 0.77

1.04

0.98, 1.10

0.58
1.12
1.86*
0.59
2.21**

0.29, 1.17
0.59, 2.12
1.04, 3.32
0.25, 1.42
1.25, 3.91

1.42

0.73, 2.77

Temptation for CAS on PrEP
B
AOR
95% CI

0.98
1.47
2.82**
1.23

0.95, 1.01
0.57, 3.84
1.33, 5.98
0.57, 2.69

-0.03
0.39
0.42
0.73

0.97
1.47
1.53
2.08

0.95, 1.00
0.59, 3.64
0.75, 3.09
0.99, 4.38

1.03

0.96, 1.10

0.03

1.03

0.97, 1.10

0.85
1.11
1.35
0.61
5.51***

0.39, 1.83
0.54, 2.29
0.69, 2.63
0.22, 1.69
2.65, 11.46

0.43
0.04
0.84
0.82
1.27

1.54
1.04
2.32**
2.28
3.57***

0.71, 3.32
0.50, 2.14
1.21, 4.44
0.87, 5.95
1.91, 6.66

12-month assessment (ref = baseline)b
0.65
1.91
0.87, 4.18
-0.66
0.52
0.25, 1.07
Note. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001; a Between-person time was coded as the month of the participant's enrollment
(0 through 27) which was mean centered and time invariant (i.e., constant for the same participant over time); b Withinparticipant time was dichotomously coded as the month of the assessment (BL = 0, 12M = 1) and was time-varying (i.e.,
differed for the same participant over time). Age and month of enrollment were both mean centered.

